Results 101 to 110 of about 10,615,218 (316)
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
National Clinical Programme for Rare Diseases Workshop on Clinical Research in Rare Diseases
The National Clinical Programme was established in December 2013. It is an initiative of the HSE, in partnership with the Royal College of Physicians. A key objective of the Clinical Programme for Rare Diseases is to improve access for rare diseases ...
National Clinical Programme for Rare Diseases
core
Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. [PDF]
BACKGROUND: Over diagnosis of malaria contributes to improper treatment, wastage of drugs and resistance to the few available drugs. This paper attempts to estimate the rates of over diagnosis of malaria among children attending dispensaries in rural ...
L. Conteh +42 more
core +2 more sources
Role of arbutin in the inhibition of FBXO5 in hepatocellular carcinoma
Purpose This work investigated the effect of FBXO5 in hepatocellular carcinoma (HCC) and the mechanism of action of arbutin in its inhibition. Methods FBXO5 mRNA and protein expressions in the tumor were assessed using TCGA, ICGC and HPA databases.
Shuo Zhang +6 more
doaj +1 more source
BackgroundThe World Health Organization (WHO) has listed carbapenem-resistant Klebsiella pneumoniae (CRKP) as one of the key pathogens that require the highest priority for containment.
Wenchao Xie +25 more
doaj +1 more source
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Andi Lin,1,* Jian Wang,2,* Lixing Wang,3 Yaping Zhang3,4 1The Second Clinical Medical College of Fujian Medical University, Quanzhou, Fujian, 362000, People’s Republic of China; 2Department of Pathology, The Second Affiliated Hospital of ...
Lin A, Wang J, Wang L, Zhang Y
doaj
Differential expression of immune activation markers in T cells from patients with multiple myeloma
IntroductionMultiple myeloma (MM) is the second most common hematological malignancy, characterized by the abnormal proliferation of malignant plasma cells leading to the classic CRAB symptoms.
Jiaoya Lin +5 more
doaj +1 more source
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng +3 more
wiley +1 more source
Diagnosis, staging and treatment of patients with gestational trophoblastic disease
This guideline is intended for all health professionals involved in the diagnosis, staging and treatment of patients with GTD, such as gynaecologists, radiologists, pathologists, surgeons, medical oncologists, GPs and nursing staff.
National Clinical Effectiveness Committee (NCEC)
core

